Glycovariant-based lateral flow immunoassay to detect ovarian cancer–associated serum CA125

Cancer antigen 125 (CA125) is a widely used biomarker in monitoring of epithelial ovarian cancer (EOC). Due to insufficient cancer specificity of CA125, its diagnostic use is severely compromised. Abnormal glycosylation of CA125 is a unique feature of ovarian cancer cells and could improve different...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Commun Biol
Main Authors: Bayoumy, Sherif, Hyytiä, Heidi, Leivo, Janne, Talha, Sheikh M., Huhtinen, Kaisa, Poutanen, Matti, Hynninen, Johanna, Perheentupa, Antti, Lamminmäki, Urpo, Gidwani, Kamlesh, Pettersson, Kim
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7442799/
https://ncbi.nlm.nih.gov/pubmed/32826955
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s42003-020-01191-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados